ZUSELT LEON: Open Payments
NPI 1689025579 · DORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 99 payments from 20 companies in 2025. Trend: 2023 $2,183 · 2024 $2,261 · 2025 $2,075
Food & beverage: $2,065Education: $10
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 15 | $289 |
| Ardelyx, Inc. | 14 | $263 |
| Janssen Biotech, Inc. | 12 | $228 |
| Madrigal Pharmaceuticals | 10 | $206 |
| GENZYME CORPORATION | 11 | $184 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $128 |
| ABBVIE INC. | 5 | $122 |
| Regeneron Healthcare Solutions, Inc. | 3 | $91 |
| Lilly USA, LLC | 4 | $88 |
| Phathom Pharmaceuticals, Inc. | 3 | $86 |
Products named: Sucraid, DUPIXENT, IBSRELA, TREMFYA, REZDIFFRA, XIFAXAN, OMVOH, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
